Overview
Kari Alitalo is a cancer biology specialist with an H-index of 187 at University of Helsinki (Member). Has been published in The Journal of Cell Biology, Nature Reviews Molecular Cell Biology, Nature Medicine. Based in Unknown, Unknown, Global.
Biography
Kari Kustaa Alitalo is a Finnish MD and a medical researcher. He is a foreign associated member of the National Academy of Sciences of the US. He became famous for his discoveries of several receptor tyrosine kinases (RTKs) and the first growth factor capable of inducing lymphangiogenesis: vascular endothelial growth factor C (VEGF-C). In the years 1996–2007 he was Europe's second most cited author in the field of cell biology. Alitalo is currently serving as an Academy Professor for the Academy of Finland.
Affiliations & Institutions
Research Impact
5 Publications
0 Total Citations
Publication Timeline
Published In
NeuronCirc ResNatureJ Exp MedAngiogenesis
Key Publications
Molecular anatomy of adult mouse leptomeninges.
Lymphatic Malformations: Genetics, Mechanisms and Therapeutic Strategies.
VEGF-C-driven lymphatic drainage enables immunosurveillance of brain tumours.
A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules.
Consensus guidelines for the use and interpretation of angiogenesis assays.
Areas of Expertise
Medical Specialties
Clinical Knowledge & Procedures
Media Archive